Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Retatrutide adds a third arm glucagon receptor agonism which preclinical and Phase 2 data suggest contributes additional hepatic lipid mobilization and energy expenditure effects not observed with mono- or dual-agonist compounds
GHK-Cu injections aren't affected by food timing, so inject whenever is convenient
The dose-dependent nature of these side effects is well-documented in clinical trials
Follow FDA guidelines for safe sharps disposal
US$ 28.97
US$ 25.32
US$ 27.25
US$ 25.33
US$ 21.86
